View in EDS

Prenatal initiation of elexacaftor/tezacaftor/ivacaftor via carrier mother prevents congenital bilateral absence of vas deferens in a male infant with cystic fibrosis.

Saved in:
Bibliographic Details
Title: Prenatal initiation of elexacaftor/tezacaftor/ivacaftor via carrier mother prevents congenital bilateral absence of vas deferens in a male infant with cystic fibrosis.
Authors: Thee S; Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, Berlin D-13353, Germany; German Center for Child and Adolescent Health (DZKJ), Partner Site Berlin, Augustenburger Platz 1, Berlin D-13353, Germany; Berlin Institute of Health (BIH) at Charité, Anna-Louisa-Karsch-Str. 2, Berlin D-10178, Germany., Aleksander P; Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, Berlin D-13353, Germany., Lechner L; Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, Berlin D-13353, Germany; Department of Pediatric Endocrinology and Diabetology, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, Berlin D-13353, Germany., Posch H; Department of Radiology, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, Berlin D-13353, Germany., Koegel C; Department of Pediatric Radiology, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, Berlin D-13353, Germany., Mall MA; Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, Berlin D-13353, Germany; German Center for Child and Adolescent Health (DZKJ), Partner Site Berlin, Augustenburger Platz 1, Berlin D-13353, Germany; German Center for Lung Research (DZL), Associated Partner Site Berlin, Augustenburger Platz 1, Berlin D-13353, Germany., Stahl M; Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, Berlin D-13353, Germany; German Center for Child and Adolescent Health (DZKJ), Partner Site Berlin, Augustenburger Platz 1, Berlin D-13353, Germany; Berlin Institute of Health (BIH) at Charité, Anna-Louisa-Karsch-Str. 2, Berlin D-10178, Germany; German Center for Lung Research (DZL), Associated Partner Site Berlin, Augustenburger Platz 1, Berlin D-13353, Germany. Electronic address: Mirjam.stahl@charite.de.
Source: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society [J Cyst Fibros] 2026 Feb 06. Date of Electronic Publication: 2026 Feb 06.
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101128966 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5010 (Electronic) Linking ISSN: 15691993 NLM ISO Abbreviation: J Cyst Fibros Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-5010
DOI:10.1016/j.jcf.2026.02.001